Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial.
Catherine HendersonMartin KnappSusan StirlingLee ShepstoneJuliet HighClive BallardPeter BenthamAlistair BurnsNicolas FarinaChris FoxJulia FountainPaul FrancisRobert HowardIracema LeroiGill LivingstonRamin NilforooshanShirley NurockJohn T O'BrienAnnabel PriceAnn Marie SwartNaji TabetTanya TellingAlan J ThomasSube BanerjeePublished in: International psychogeriatrics (2022)
On cost-effectiveness grounds, the use of mirtazapine cannot be recommended for agitated behaviors in people living with dementia. Effective and cost-effective medications for agitation in dementia remain to be identified in cases where non-pharmacological strategies for managing agitation have been unsuccessful.